A, P., L, F., P, G., & J, W. (2015). Activation of wild-type p53 by MDM2 inhibitors: A new strategy for lymphoma treatment. Dove Medical Press.
Style de citation Chicago (17e éd.)A, Pujals, Favre L, Gaulard P, et Wiels J. Activation of Wild-type P53 by MDM2 Inhibitors: A New Strategy for Lymphoma Treatment. Dove Medical Press, 2015.
Style de citation MLA (8e éd.)A, Pujals, et al. Activation of Wild-type P53 by MDM2 Inhibitors: A New Strategy for Lymphoma Treatment. Dove Medical Press, 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.